Followers | 35 |
Posts | 182 |
Boards Moderated | 0 |
Alias Born | 05/03/2020 |
![](https://investorshub.advfn.com/uicon/743282.png?cb=1588808426)
Thursday, May 21, 2020 12:04:36 AM
Ipix could send shock waves if they decide to use Remdesivir as the placebo. They should. Practically, all nucleotide inhibitors are now useless! Bril is more likely to be effective than Leronlimab, Imo, since upregulation of defensin mimetics is enough to trigger an adaptive immune response to make its "indirect" antiviral effects but also in addressing severe patients with pneumonia and/or sepsis.
Now it will be interesting how TIH will look at this in terms of funding.
Will they run the IV portion only Or will they the po version as well for preventative? I expect grants and or funding to happen soon. A partnership could happen too as well, IMO. BRIL SHOULD ALSO WORK FOR OTHER PANDEMIC FLU, which is another business opportunity for IPIX.
Not worried about the next readout. It's in the bag already, some are just a bit slow or unable to assess or foresee things rather quickly; Pass the salt please!
If you find yourself betting against the company, what are you going to do about it? Checkmate! Both sides will catch fire and it's just a matter of time before this sp hits $1, $2, or higher. The valuation is very cheap here with IPIX and it's long overdue for a major correction!
My assumptions about their science have been spot on. The next readout will confirm that as well. GLTA.
We appreciate your business!
TAGB
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM